HighTower Advisors
VIVE

HighTower Advisors’s VIVEVE MED INC VIVE Stock Holding History

HighTower Advisors’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-43,591
Closed -$549K – 2569
2019
Q4 		$549K Sell
43,591
-94
-0.2% -$2.67K ﹤0.01% 1408
2019
Q3 		$1.93M Buy
43,685
+41,764
+2,174% +$7.53M 0.01% 898
2019
Q2 		$728K Buy
1,921
+10
+0.5% +$5.42K ﹤0.01% 1340
2019
Q1 		$1.79M Hold
1,911
– – 0.01% 897
2018
Q4 		$2M Buy
1,911
+89
+5% +$214K 0.02% 765
2018
Q3 		$4.88M Buy
1,822
+1
+0.1% +$2.83K 0.04% 517
2018
Q2 		$4.96M Buy
1,821
+61
+3% +$176K 0.04% 502
2018
Q1 		$6.45M Buy
1,760
+10
+0.6% +$43.5K 0.05% 387
2017
Q4 		$8.7M Buy
1,750
+2
+0.1% +$10.4K 0.07% 297
2017
Q3 		$9.16M Buy
1,748
+24
+1% +$148K 0.08% 270
2017
Q2 		$12.4M Buy
1,724
+430
+33% +$3.21M 0.11% 198
2017
Q1 		$8.19M Buy
1,294
+349
+37% +$1.7M 0.08% 276
2016
Q4 		$4.87M Buy
945
+34
+4% +$202K 0.05% 388
2016
Q3 		$6.57M Buy
911
+260
+40% +$1.73M 0.08% 281
2016
Q2 		$2.67M Buy
+651
New +$3.03M 0.03% 529

Other funds holding VIVE

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

HighTower Advisors's VIVE Position: Q1 2020 in Review

HighTower Advisors sold out of VIVEVE MED INC (VIVE) in Q1 2020, closing a stake of 43,591 shares — an estimated $549K sold.

HighTower Advisors first reported a position in VIVE in Q2 2016 and held it in 15 quarters. The position peaked at $12.4M in Q2 2017. 11 funds tracked by Wall St. Rank hold VIVE as of Q1 2020.

  • HighTower Advisors reported no remaining VIVEVE MED INC position as of Q1 2020 after selling out during the quarter.
  • HighTower Advisors sold 43,591 VIVEVE MED INC shares in Q1 2020, an estimated $549K.
  • HighTower Advisors first reported a position in VIVEVE MED INC in Q2 2016 and held it in 15 quarters.
  • HighTower Advisors's VIVEVE MED INC position peaked at $12.4M in Q2 2017.
  • 11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2020.

Based on HighTower Advisors's 13F filing for Q1 2020, filed 21 May 2020.